Skip to main content

Nivolumab in chemotherapy-resistant cervical cancer: report of a vulvitis as a novel immune-related adverse event and molecular analysis of a persistent complete response

Access & Citations

  • 5199
    Article Accesses
  • 0
    Web of Science
  • 9
    CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

Online attention

Altmetric score 1
  • 3 tweeters
  • 40 Mendeley

This article is in the 23rd percentile (ranked 273,224th) of the 378,026 tracked articles of a similar age in all journals and the 2nd percentile (ranked 88th) of the 94 tracked articles of a similar age in Journal for ImmunoTherapy of Cancer

View more on Altmetric

Altmetric calculates a score based on the online attention an article receives. Each coloured thread in the circle represents a different type of online attention. The number in the centre is the Altmetric score. Social media and mainstream news media are the main sources that calculate the score. Reference managers such as Mendeley are also tracked but do not contribute to the score. Older articles often score higher because they have had more time to get noticed. To account for this, Altmetric has included the context data for other articles of a similar age.